explore -WSS

explore

author：focus 2025-08-25 16:35:24 - browse：4949

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Senate panel clears PBM, hopsital reforms

WSS

‘Oppenheimer’ and the risks of AI in health care

Wildfire pollution widens asthma inequities on Long Island

New safety details link Apellis eye drug to rare cases of blindness

‘Oppenheimer’ and the risks of AI in health care

The high personal cost of affirmative action for Black doctors

White House calls on federal agencies to crack down on AI abuses

focus

explore

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare will require more price transparency from hospitals

Continuity nursing helped my family in our darkest PICU moments

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Wildfire smoke exposes gaps in outdoor worker protections

Mitch McConnell episode has important public health takeaway

What does generative AI mean for health care? We asked experts

Mega Millions pot grows to $1.25 billion after no winner

focus

EQRx, failed developer of low

Trump indictment: Who are the 'co

Free speech concerns arise in wake of journal editor Eisen's firing

EQRx, failed developer of low

No plane should take off without an EpiPen onboard

5 important ways Henrietta Lacks changed medical science

entertainment

leisure time

hotspot

hotspot